Zynerba Pharmaceuticals, Inc. (0M40.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 05:20PM BST
| Previous close | 1.1700 |
| Open | 0.9811 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 0.9811 - 0.9811 |
| 52-week range | 0.9811 - 0.9811 |
| Volume | |
| Avg. volume | N/A |
| Market cap | 36.855M |
| Beta (5Y monthly) | 2.19 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.9620 |
| Earnings date | 08 Aug 2022 - 12 Aug 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Zynerba (ZYNE) Loses 29.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Zynerba (ZYNE) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
- Simply Wall St.
Companies Like Zynerba Pharmaceuticals (NASDAQ:ZYNE) Are In A Position To Invest In Growth
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
© 2022 Yahoo. All rights reserved.
